Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline
Abstract Background Anecdotal reports support the position that the adulticidal heartworm treatment utilizing doxycycline and Advantage Multi®/Advocate® for Dogs (10% imidacloprid + 2.5% moxidectin) has successfully converted antigen-positive dogs to antigen-negative. To date, no controlled experime...
Main Authors: | Molly D. Savadelis, Cameon M. Ohmes, Joe A. Hostetler, Terry L. Settje, Robert Zolynas, Michael T. Dzimianski, Andrew R. Moorhead |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-017-2190-9 |
Similar Items
-
Heat pretreatment of canine samples to evaluate efficacy of imidacloprid + moxidectin and doxycycline in heartworm treatment
by: Alexandre José Rodrigues Bendas, et al.
Published: (2017-05-01) -
Safety of Simparica Trio® (sarolaner, pyrantel, moxidectin) in heartworm-infected dogs
by: Sheerin Mathur, et al.
Published: (2023-03-01) -
Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
by: Tom L. McTier, et al.
Published: (2019-09-01) -
Moxidectin steady state prior to inoculation protects cats from subsequent, repeated infection with Dirofilaria immitis
by: Susan E Little, et al.
Published: (2015-02-01) -
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
by: Tom L. McTier, et al.
Published: (2019-07-01)